More than half of vaccines go to waste globally every year because of temperature control, logistics and shipment-related issues.
Logistical hurdles are a significant risk for efforts to rapidly distribute COVID-19 vaccines, but they have resulted in booming business for companies such as private California-based Cloudleaf Inc, Germany’s SAP SE and others that sell technology for monitoring shipments from factory freezer to shot in the arm.
Cloudleaf, backed by Intel Capital, the venture arm of chipmaker Intel Corp, uses sensors attached to material containers to track location, temperature, humidity, vibration and acceleration.
The sensors send data to the cloud, where an artificial intelligence algorithm can predict if action is needed to prevent a product from becoming exposed to temperatures outside the recommended range, known as excursions.
Cloudleaf chief executive officer Mahesh Veerina said that orders have jumped 500 percent this year.
To keep pace, the firm had to grow its workforce and increase capital spending by as much as 80 percent, he said, adding that he expects similar growth in capital spending next year.
“I have CEOs calling and saying: ‘Hey, can we get this up in the next four to five weeks?’” Veerina said.
The booming business has also increased the need for fresh capital. Cloudleaf has raised millions of US dollars this year and has plans to raise “very significant” amounts of capital next year too, Veerina said.
Pfizer Inc and German partner BioNTech SE’s vaccine must be shipped and stored at ultra-cold temperatures, or on dry ice, and can only last at standard refrigerator temperatures for up to five days.
In contrast, Moderna Inc’s vaccine, which on Friday received US regulatory authorization, can be kept in a regular refrigerator for up to a month.
These varying requirements have increased the risks of logistical mishaps.
A quarter of all vaccines are degraded by the time they arrive at their destination due to incorrect shipping procedures, according to the International Air Transport Association.
Losses associated with temperature excursions in the healthcare industry are estimated at about US$35 billion annually.
Given the scale of the COVID-19 vaccine rollout, the losses could be significantly higher next year, analysts said.
At least two trays of COVID-19 vaccine doses delivered in California needed to be replaced after their storage temperatures dipped below minus-80°C, US Army General Gustave Perna said on Wednesday.
Blockchain and sensor-enabled cold chain monitoring tools can help reduce the losses, and mitigate the risks of theft or counterfeiting of the vaccines.
Moderna is using SAP’s digital solutions to help serialize and distribute its vaccine. The applications are designed to prevent counterfeit medicines and enable collaboration with contract manufacturers and wholesalers.
Similarly, Israeli start-up Varcode Ltd, which makes smart tags that measure time and temperature, and can track and trace products throughout the supply chain, has seen a multifold jump in orders.
Before the pandemic, the orders for Varcode’s tags would range between 100,000 to 1 million units.
Since the middle of this year, some of the companies involved in the vaccine distribution have been asking for billions of tags, Varcode chief executive officer Joe Battoe said.
This, in turn, has led to a 200 percent increase in Varcode’s capital spending this year.
Battoe said that the pandemic had “been good for our business.”
Varcode’s low-cost cloud-based, blockchain-enabled technology sends out alerts when a product goes outside its prescribed temperature range, and captures the cumulative time the product has been outside of the temperature range.
Its smart tags are serialized and need just a smart phone to scan them. Every scan leaves a digital trail, reducing the risks of theft or counterfeiting.
The tags can track individual vials, making them a better fit for the vaccine distribution in small and rural areas which might require fewer than the minimum order of doses.
Varcode’s tags are produced in Israel, but the soaring demand has prompted it to invest in a unique printer and an applicator that would generate the tags on site where the vaccines are being manufactured and apply them to carts going down the conveyor belt in real time.
The US$5 billion global cold chain monitoring technology market could grow 50 percent next year, thanks to the vaccine rollout, Battoe said.
“I don’t think we would be garnering the attention ... had it not been for the scale and the sensitivity of these vaccines,” he said.
EXTRATERRITORIAL REACH: China extended its legal jurisdiction to ban some dual-use goods of Chinese origin from being sold to the US, even by third countries Beijing has set out to extend its domestic laws across international borders with a ban on selling some goods to the US that applies to companies both inside and outside China. The new export control rules are China’s first attempt to replicate the extraterritorial reach of US and European sanctions by covering Chinese products or goods with Chinese parts in them. In an announcement this week, China declared it is banning the sale of dual-use items to the US military and also the export to the US of materials such as gallium and germanium. Companies and people overseas would be subject to
WORLD DOMINATION: TSMC’s lead over second-placed Samsung has grown as the latter faces increased Chinese competition and the end of clients’ product life cycles Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) retained the No. 1 title in the global pure-play wafer foundry business in the third quarter of this year, seeing its market share growing to 64.9 percent to leave South Korea’s Samsung Electronics Co, the No. 2 supplier, further behind, Taipei-based TrendForce Corp (集邦科技) said in a report. TSMC posted US$23.53 billion in sales in the July-September period, up 13.0 percent from a quarter earlier, which boosted its market share to 64.9 percent, up from 62.3 percent in the second quarter, the report issued on Monday last week showed. TSMC benefited from the debut of flagship
TENSE TIMES: Formosa Plastics sees uncertainty surrounding the incoming Trump administration in the US, geopolitical tensions and China’s faltering economy Formosa Plastics Group (台塑集團), Taiwan’s largest industrial conglomerate, yesterday posted overall revenue of NT$118.61 billion (US$3.66 billion) for last month, marking a 7.2 percent rise from October, but a 2.5 percent fall from one year earlier. The group has mixed views about its business outlook for the current quarter and beyond, as uncertainty builds over the US power transition and geopolitical tensions. Formosa Plastics Corp (台灣塑膠), a vertically integrated supplier of plastic resins and petrochemicals, reported a monthly uptick of 15.3 percent in its revenue to NT$18.15 billion, as Typhoon Kong-rey postponed partial shipments slated for October and last month, it said. The
COLLABORATION: The operations center shows the close partnership between Taiwan and Japan in the field of semiconductors, Minister of Economic Affairs J.W. Kuo said Tokyo Electron Ltd, Asia’s biggest semiconductor equipment supplier, yesterday launched a NT$2 billion (US$61.5 million) operations center in Tainan as it aims to expand capacity and meet growing demand. Its new Taiwan Operations Center is expected to help customers release their products faster, boost production efficiency and shorten equipment repair time in a cost-effective way, the company said. The center is about a five-minute drive from the factories of its major customers such as Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) advanced 3-nanometer and 2-nanometer fabs. The operations center would have about 1,000 employees when it is fully utilized, the company
RSS